128 results on '"Marsland BJ"'
Search Results
2. Lower Airway Microbiota Associates with Inflammatory Phenotype in Severe Preschool Wheeze
- Author
-
Robinson, PFM, Pattaroni, C, Cook, J, Gregory, L, Alonso, AM, Fleming, LJ, Lloyd, CM, Bush, A, Marsland, BJ, Saglani, S, British Lung Foundation, National Institute for Health Research, Royal Brompton & Harefield NHS Foundation Trust, and Asthma UK
- Subjects
Science & Technology ,Allergy ,1107 Immunology ,Immunology ,QUALITY ,CHILDREN ,Life Sciences & Biomedicine - Published
- 2019
3. Tackling food allergies by microbiome modulation.
- Author
-
Marsland BJ and Harris NL
- Subjects
- Humans, Gastrointestinal Microbiome, Animals, Food Hypersensitivity immunology, Food Hypersensitivity prevention & control, Food Hypersensitivity microbiology, Microbiota
- Published
- 2024
- Full Text
- View/download PDF
4. Breaking down silos: The Gastroenterology Immunology Neuroscience (GIN) Discovery Program - a new model for research.
- Author
-
Silva J, Halmos EP, Marsland BJ, and Mychasiuk R
- Subjects
- Animals, Humans, Allergy and Immunology, Biomedical Research, Brain-Gut Axis, Gastroenterology, Neurosciences
- Abstract
The Gastroenterology Immunology Neuroscience (GIN) Discovery Program represents a new model for research that overcomes the limitations imposed by traditional "research silos" in science. By uniting these three fields, the GIN Program aims to enhance the understanding and treatment of chronic conditions through a system-wide perspective focusing on the gut-immune-brain axis. Key initiatives include monthly interdisciplinary seminars, an annual symposium, and GINnovate, a commercialization and entrepreneurship event. Additionally, the program offers a seed grant competition for early and mid-career researchers, promoting advancements in gut-immune-brain axis research through the power of collaboration. The GIN Program in a short period of time has facilitated the formation of a vibrant community, captivating attention from both national and international institutions. This effort to break down barriers in research aims to inspire similar models that prioritize open communication, mutual respect and a commitment to impactful science., (© 2024 the Australian and New Zealand Society for Immunology, Inc.)
- Published
- 2024
- Full Text
- View/download PDF
5. Deep multiomic profiling reveals molecular signatures that underpin preschool wheeze and asthma.
- Author
-
Macowan M, Pattaroni C, Bonner K, Chatzis R, Daunt C, Gore M, Custovic A, Shields MD, Power UF, Grigg J, Roberts G, Ghazal P, Schwarze J, Turner S, Bush A, Saglani S, Lloyd CM, and Marsland BJ
- Abstract
Background: Wheezing in childhood is prevalent, with over one-half of all children experiencing at least 1 episode by age 6. The pathophysiology of wheeze, especially why some children develop asthma while others do not, remains unclear., Objectives: This study addresses the knowledge gap by investigating the transition from preschool wheeze to asthma using multiomic profiling., Methods: Unsupervised, group-agnostic integrative multiomic factor analysis was performed using host/bacterial (meta)transcriptomic and bacterial shotgun metagenomic datasets from bronchial brush samples paired with metabolomic/lipidomic data from bronchoalveolar lavage samples acquired from children 1-17 years old., Results: Two multiomic factors were identified: one characterizing preschool-aged recurrent wheeze and another capturing an inferred trajectory from health to wheeze and school-aged asthma. Recurrent wheeze was driven by type 1-immune signatures, coupled with upregulation of immune-related and neutrophil-associated lipids and metabolites. Comparatively, progression toward asthma from ages 1 to 18 was dominated by changes related to airway epithelial cell gene expression, type 2-immune responses, and constituents of the airway microbiome, such as increased Haemophilus influenzae., Conclusions: These factors highlighted distinctions between an inflammation-related phenotype in preschool wheeze, and the predominance of airway epithelial-related changes linked with the inferred trajectory toward asthma. These findings provide insights into the differential mechanisms driving the progression from wheeze to asthma and may inform targeted therapeutic strategies., Competing Interests: Disclosure statement The study is supported by a Wellcome Trust grant (108818), a L.E.W. Carty Charitable Fund awarded to C.P., funding from The Hospital Research Foundation Group (2022-SF-EOI-001) awarded to B.J.M. and C.P., and a National Health and Medical Research Council Senior Research Fellowship (1154344) awarded to B.J.M. Disclosure of potential conflict of interest: The authors declare that they have no relevant conflicts of interest., (Copyright © 2024 The Authors. Published by Elsevier Inc. All rights reserved.)
- Published
- 2024
- Full Text
- View/download PDF
6. Helminth infection driven gastrointestinal hypermotility is independent of eosinophils and mediated by alterations in smooth muscle instead of enteric neurons.
- Author
-
Wang H, Barry K, Zaini A, Coakley G, Moyat M, Daunt CP, Wickramasinghe LC, Azzoni R, Chatzis R, Yumnam B, Camberis M, Le Gros G, Perdijk O, Foong JPP, Bornstein JC, Marsland BJ, and Harris NL
- Subjects
- Animals, Mice, Nematospiroides dubius physiology, Nematospiroides dubius immunology, Strongylida Infections immunology, Strongylida Infections parasitology, Intestinal Diseases, Parasitic immunology, Intestinal Diseases, Parasitic parasitology, Helminthiasis immunology, Helminthiasis parasitology, Neurons parasitology, Neurons metabolism, Mice, Inbred C57BL, Eosinophils immunology, Muscle, Smooth parasitology, Enteric Nervous System parasitology, Enteric Nervous System immunology, Gastrointestinal Motility physiology, Nippostrongylus
- Abstract
Intestinal helminth infection triggers a type 2 immune response that promotes a 'weep-and sweep' response characterised by increased mucus secretion and intestinal hypermotility, which function to dislodge the worm from its intestinal habitat. Recent studies have discovered that several other pathogens cause intestinal dysmotility through major alterations to the immune and enteric nervous systems (ENS), and their interactions, within the gastrointestinal tract. However, the involvement of these systems has not been investigated for helminth infections. Eosinophils represent a key cell type recruited by the type 2 immune response and alter intestinal motility under steady-state conditions. Our study aimed to investigate whether altered intestinal motility driven by the murine hookworm, Nippostrongylus brasiliensis, infection involves eosinophils and how the ENS and smooth muscles of the gut are impacted. Eosinophil deficiency did not influence helminth-induced intestinal hypermotility and hypermotility did not involve gross structural or functional changes to the ENS. Hypermotility was instead associated with a dramatic increase in smooth muscle thickness and contractility, an observation that extended to another rodent nematode, Heligmosomoides polygyrus. In summary our data indicate that, in contrast to other pathogens, helminth-induced intestinal hypermotility is driven by largely by myogenic, rather than neurogenic, alterations with such changes occurring independently of eosinophils. (<300 words)., Competing Interests: The authors have declared that no competing interests exist., (Copyright: © 2024 Wang et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.)
- Published
- 2024
- Full Text
- View/download PDF
7. Antibiotic-driven dysbiosis in early life disrupts indole-3-propionic acid production and exacerbates allergic airway inflammation in adulthood.
- Author
-
Perdijk O, Butler A, Macowan M, Chatzis R, Bulanda E, Grant RD, Harris NL, Wypych TP, and Marsland BJ
- Subjects
- Animals, Mice, Lung immunology, Lung pathology, Mice, Inbred C57BL, Female, Inflammation immunology, Disease Models, Animal, Mitochondria metabolism, Cytokines metabolism, Hypersensitivity immunology, Propionates, Dysbiosis immunology, Indoles pharmacology, Anti-Bacterial Agents adverse effects, Anti-Bacterial Agents pharmacology, Gastrointestinal Microbiome drug effects, Gastrointestinal Microbiome immunology, Asthma immunology, Pyroglyphidae immunology
- Abstract
Antibiotic use in early life disrupts microbial colonization and increases the risk of developing allergies and asthma. We report that mice given antibiotics in early life (EL-Abx), but not in adulthood, were more susceptible to house dust mite (HDM)-induced allergic airway inflammation. This susceptibility was maintained even after normalization of the gut microbiome. EL-Abx decreased systemic levels of indole-3-propionic acid (IPA), which induced long-term changes to cellular stress, metabolism, and mitochondrial respiration in the lung epithelium. IPA reduced mitochondrial respiration and superoxide production and altered chemokine and cytokine production. Consequently, early-life IPA supplementation protected EL-Abx mice against exacerbated HDM-induced allergic airway inflammation in adulthood. These results reveal a mechanism through which EL-Abx can predispose the lung to allergic airway inflammation and highlight a possible preventative approach to mitigate the detrimental consequences of EL-Abx., Competing Interests: Declaration of interests The authors declare no competing interests., (Copyright © 2024 Elsevier Inc. All rights reserved.)
- Published
- 2024
- Full Text
- View/download PDF
8. Neuroimmunology of the Lung.
- Author
-
Azzoni R, Perdijk O, Harris NL, and Marsland BJ
- Subjects
- Humans, Animals, Lung Diseases immunology, Lung Diseases etiology, Brain immunology, Brain physiology, Neuroimmunomodulation, Lung immunology
- Abstract
Barrier tissues are highly innervated by sensory and autonomic nerves that are positioned in close proximity to both stromal and immune cell populations. Together with a growing awareness of the far-reaching consequences of neuroimmune interactions, recent studies have uncovered key mechanisms through which they contribute to organ homeostasis and immunity. It has also become clear that dysregulation of such interactions is implicated in the development of chronic lung diseases. This review describes the characteristics of the lung nervous system and discusses the molecular mechanisms that underlie lung neuroimmune interactions in infection and disease. We have contextualized the current literature and identified opportune areas for further investigation. Indeed, both the lung-brain axis and local neuroimmune interactions hold enormous potential for the exploration and development of novel therapeutic strategies targeting lung diseases.
- Published
- 2024
- Full Text
- View/download PDF
9. The longitudinal microbial and metabolic landscape of infant cystic fibrosis: the gut-lung axis.
- Author
-
Frayman KB, Macowan M, Caparros-Martin J, Ranganathan SC, and Marsland BJ
- Subjects
- Humans, Infant, Male, Female, Infant, Newborn, Longitudinal Studies, Case-Control Studies, Metabolome, Metabolomics, Anti-Bacterial Agents therapeutic use, Child, Preschool, Cystic Fibrosis microbiology, Cystic Fibrosis metabolism, Bronchoalveolar Lavage Fluid microbiology, Feces microbiology, RNA, Ribosomal, 16S genetics, Lung microbiology, Lung metabolism, Gastrointestinal Microbiome
- Abstract
Background and Aim: In cystic fibrosis, gastrointestinal dysfunction and lower airway infection occur early and are independently associated with poorer outcomes in childhood. This study aimed to define the relationship between the microbiota at each niche during the first 2 years of life, its association with growth and airway inflammation, and explanatory features in the metabolome., Materials and Methods: 67 bronchoalveolar lavage fluid (BALF), 62 plasma and 105 stool samples were collected from 39 infants with cystic fibrosis between 0 and 24 months who were treated with prophylactic antibiotics. 16S rRNA amplicon and shotgun metagenomic sequencing were performed on BALF and stool samples, respectively; metabolomic analyses were performed on all sample types. Sequencing data from healthy age-matched infants were used as controls., Results: Bacterial diversity increased over the first 2 years in both BALF and stool, and microbial maturation was delayed in comparison to healthy controls from the RESONANCE cohort. Correlations between their respective abundance in both sites suggest stool may serve as a noninvasive alternative for detecting BALF Pseudomonas and Veillonella . Multisite metabolomic analyses revealed age- and growth-related changes, associations with neutrophilic airway inflammation, and a set of core systemic metabolites. BALF Pseudomonas abundance was correlated with altered stool microbiome composition and systemic metabolite alterations, highlighting a complex gut-plasma-lung interplay and new targets with therapeutic potential., Conclusion: Exploration of the gut-lung microbiome and metabolome reveals diverse multisite interactions in cystic fibrosis that emerge in early life. Gut-lung metabolomic links with airway inflammation and Pseudomonas abundance warrant further investigation for clinical utility, particularly in non-expectorating patients., Competing Interests: Conflict of interest: K.B. Frayman reports grants from NHMRC Postgraduate Scholarship, Royal Australasian College of Physicians Paediatrics and Child Health Division National Health and Medical Research Council (NHMRC) Award for Excellence (top-up), Clifford Family PhD Scholarship and Australian Government Research Training Program Scholarship, lecture honoraria from Vertex Pharmaceuticals, travel support from Australian Cystic Fibrosis Trust Ann Maree Bosch Career Fellowship, and a steering committee role for the Australian Cystic Fibrosis Data Registry, outside the submitted work. The other authors have no potential conflicts of interest to disclose., (Copyright ©The authors 2024. For reproduction rights and permissions contact permissions@ersnet.org.)
- Published
- 2024
- Full Text
- View/download PDF
10. The microbiome: an integral player in immune homeostasis and inflammation in the respiratory tract.
- Author
-
Perdijk O, Azzoni R, and Marsland BJ
- Subjects
- Infant, Newborn, Humans, Child, Lung microbiology, Inflammation pathology, Bacteria metabolism, Homeostasis, Microbiota, Asthma
- Abstract
The last decade of microbiome research has highlighted its fundamental role in systemic immune and metabolic homeostasis. The microbiome plays a prominent role during gestation and into early life, when maternal lifestyle factors shape immune development of the newborn. Breast milk further shapes gut colonization, supporting the development of tolerance to commensal bacteria and harmless antigens while preventing outgrowth of pathogens. Environmental microbial and lifestyle factors that disrupt this process can dysregulate immune homeostasis, predisposing infants to atopic disease and childhood asthma. In health, the low-biomass lung microbiome, together with inhaled environmental microbial constituents, establishes the immunological set point that is necessary to maintain pulmonary immune defense. However, in disease perturbations to immunological and physiological processes allow the upper respiratory tract to act as a reservoir of pathogenic bacteria, which can colonize the diseased lung and cause severe inflammation. Studying these host-microbe interactions in respiratory diseases holds great promise to stratify patients for suitable treatment regimens and biomarker discovery to predict disease progression. Preclinical studies show that commensal gut microbes are in a constant flux of cell division and death, releasing microbial constituents, metabolic by-products, and vesicles that shape the immune system and can protect against respiratory diseases. The next major advances may come from testing and utilizing these microbial factors for clinical benefit and exploiting the predictive power of the microbiome by employing multiomics analysis approaches.
- Published
- 2024
- Full Text
- View/download PDF
11. Multi-omics integration reveals a nonlinear signature that precedes progression of lung fibrosis.
- Author
-
Pattaroni C, Begka C, Cardwell B, Jaffar J, Macowan M, Harris NL, Westall GP, and Marsland BJ
- Abstract
Objectives: Idiopathic pulmonary fibrosis (IPF) is a devastating progressive interstitial lung disease with poor outcomes. While decades of research have shed light on pathophysiological mechanisms associated with the disease, our understanding of the early molecular events driving IPF and its progression is limited. With this study, we aimed to model the leading edge of fibrosis using a data-driven approach., Methods: Multiple omics modalities (transcriptomics, metabolomics and lipidomics) of healthy and IPF lung explants representing different stages of fibrosis were combined using an unbiased approach. Multi-Omics Factor Analysis of datasets revealed latent factors specifically linked with established fibrotic disease (Factor1) and disease progression (Factor2)., Results: Features characterising Factor1 comprised well-established hallmarks of fibrotic disease such as defects in surfactant, epithelial-mesenchymal transition, extracellular matrix deposition, mitochondrial dysfunction and purine metabolism. Comparatively, Factor2 identified a signature revealing a nonlinear trajectory towards disease progression. Molecular features characterising Factor2 included genes related to transcriptional regulation of cell differentiation, ciliogenesis and a subset of lipids from the endocannabinoid class. Machine learning models, trained upon the top transcriptomics features of each factor, accurately predicted disease status and progression when tested on two independent datasets., Conclusion: This multi-omics integrative approach has revealed a unique signature which may represent the inflection point in disease progression, representing a promising avenue for the identification of therapeutic targets aimed at addressing the progressive nature of the disease., Competing Interests: The authors declare no conflict of interest., (© 2024 The Authors. Clinical & Translational Immunology published by John Wiley & Sons Australia, Ltd on behalf of Australian and New Zealand Society for Immunology, Inc.)
- Published
- 2024
- Full Text
- View/download PDF
12. Butyrate regulates neutrophil homeostasis and impairs early antimicrobial activity in the lung.
- Author
-
Dang AT, Begka C, Pattaroni C, Caley LR, Floto RA, Peckham DG, and Marsland BJ
- Subjects
- Humans, Neutrophils, Fatty Acids, Volatile metabolism, Lung pathology, Inflammation metabolism, Homeostasis, Butyrates pharmacology, Butyrates metabolism, Anti-Infective Agents metabolism
- Abstract
Short-chain fatty acids (SCFAs) are metabolites that are produced after microbial fermentation of dietary fiber and impact cell metabolism and anti-inflammatory pathways both locally in the gut and systemically. In preclinical models, administration of SCFAs, such as butyrate, ameliorates a range of inflammatory disease models including allergic airway inflammation, atopic dermatitis, and influenza infection. Here we report the effect of butyrate on a bacteria-induced acute neutrophil-driven immune response in the airways. Butyrate impacted discrete aspects of hematopoiesis in the bone marrow resulting in the accumulation of immature neutrophils. During Pseudomonas aeruginosa infection, butyrate treatment led to the enhanced mobilization of neutrophils to the lungs as a result of increased CXCL2 expression by lung macrophages. Despite this increase in granulocyte numbers and their enhanced phagocytic capacity, neutrophils failed to control early bacterial growth. Butyrate reduced the expression of nicotinamide adenine dinucleotide phosphate, oxidase complex components required for reactive oxygen species production, and reduced secondary granule enzymes, culminating in impaired bactericidal activity. These data reveal that SCFAs tune neutrophil maturation and effector function in the bone marrow under homeostatic conditions, potentially to mitigate against excessive granulocyte-driven immunopathology, but their consequently restricted bactericidal capacity impairs early control of Pseudomonas infection., (Copyright © 2023 The Author(s). Published by Elsevier Inc. All rights reserved.)
- Published
- 2023
- Full Text
- View/download PDF
13. The skin microbiome in the first year of life and its association with atopic dermatitis.
- Author
-
Rapin A, Rehbinder EM, Macowan M, Pattaroni C, Lødrup Carlsen KC, Harris NL, Jonassen CM, Landrø L, Lossius AH, Nordlund B, Rudi K, Skjerven HO, Cathrine Staff A, Söderhäll C, Ubags N, Vettukattil R, and Marsland BJ
- Subjects
- Infant, Infant, Newborn, Humans, Pregnancy, Female, Cesarean Section, RNA, Ribosomal, 16S genetics, Cohort Studies, Skin microbiology, Bacteria genetics, Water, Dermatitis, Atopic, Microbiota, Hypersensitivity
- Abstract
Background: Early-life microbial colonization of the skin may modulate the immune system and impact the development of atopic dermatitis (AD) and allergic diseases later in life. To address this question, we assessed the association between the skin microbiome and AD, skin barrier integrity and allergic diseases in the first year of life. We further explored the evolution of the skin microbiome with age and its possible determinants, including delivery mode., Methods: Skin microbiome was sampled from the lateral upper arm on the first day of life, and at 3, 6, and 12 months of age. Bacterial communities were assessed by 16S rRNA gene amplicon sequencing in 346 infants from the PreventADALL population-based birth cohort study, representing 970 samples. Clinical investigations included skin examination and skin barrier function measured as trans-epidermal water loss (TEWL) at the site and time of microbiome sampling at 3, 6, and 12 months. Parental background information was recorded in electronic questionnaires, and delivery mode (including vaginal delivery (VD), VD in water, elective caesarean section (CS) and emergency CS) was obtained from maternal hospital charts., Results: Strong temporal variations in skin bacterial community composition were found in the first year of life, with distinct patterns associated with different ages. Confirming our hypothesis, skin bacterial community composition in the first year of life was associated with skin barrier integrity and later onsets of AD. Delivery mode had a strong impact on the microbiome composition at birth, with each mode leading to distinct patterns of colonization. Other possible determinants of the skin microbiome were identified, including environmental and parental factors as well as breastfeeding., Conclusion: Skin microbiome composition during infancy is defined by age, transiently influenced by delivery mode as well as environmental, parental factors and breastfeeding. The microbiome is also associated with skin barrier integrity and the onset of AD., (© 2023 The Authors. Allergy published by European Academy of Allergy and Clinical Immunology and John Wiley & Sons Ltd.)
- Published
- 2023
- Full Text
- View/download PDF
14. Gut instinct: Sex differences in the gut microbiome are associated with changes in adolescent nociception following maternal separation in rats.
- Author
-
Salberg S, Macowan M, Yamakawa GR, Beveridge JK, Noel M, Marsland BJ, and Mychasiuk R
- Subjects
- Animals, Female, Male, Rats, Instinct, Maternal Deprivation, Nociception, Rats, Sprague-Dawley, RNA, Ribosomal, 16S genetics, Sex Characteristics, Chronic Pain, Gastrointestinal Microbiome genetics
- Abstract
Adolescent chronic pain is a growing public health epidemic. Our understanding of its etiology is limited; however, several factors can increase susceptibility, often developing in response to an acute pain trigger such as a surgical procedure or mild traumatic brain injury (mTBI), or an adverse childhood experience (ACE). Additionally, the prevalence and manifestation of chronic pain is sexually dimorphic, with double the rates in females than males. Despite this, the majority of pre-clinical pain research focuses on males, leaving a gap in mechanistic understanding for females. Given that emerging evidence has linked the gut microbiome and the brain-gut-immune axis to various pain disorders, we aimed to investigate sex-dependent changes in taxonomic and functional gut microbiome features following an ACE and acute injury as chronic pain triggers. Male and female Sprague Dawley rat pups were randomly assigned to either a maternal separation (MS) or no stress paradigm, then further into a sham, mTBI, or surgery condition. Chronically, the von Frey test was used to measure mechanical nociception, and fecal samples were collected for 16S rRNA sequencing. Animals in the surgery group had an increase in pain sensitivity when compared to mTBI and sham groups, and this was complemented by changes to the gut microbiome. In addition, significant sex differences were identified in gut microbiome composition, which were exacerbated in response to MS. Overall, we provide preliminary evidence for sex differences and ACE-induced changes in bacterial composition that, when combined, may be contributing to heterogeneity in pain outcomes., (© 2023 The Authors. Developmental Neurobiology published by Wiley Periodicals LLC.)
- Published
- 2023
- Full Text
- View/download PDF
15. Systems prediction of chronic lung allograft dysfunction: Results and perspectives from the Cohort of Lung Transplantation and Systems prediction of Chronic Lung Allograft Dysfunction cohorts.
- Author
-
Pison C, Tissot A, Bernasconi E, Royer PJ, Roux A, Koutsokera A, Coiffard B, Renaud-Picard B, Le Pavec J, Mordant P, Demant X, Villeneuve T, Mornex JF, Nemska S, Frossard N, Brugière O, Siroux V, Marsland BJ, Foureau A, Botturi K, Durand E, Pellet J, Danger R, Auffray C, Brouard S, Nicod L, and Magnan A
- Abstract
Background: Chronic lung allograft dysfunction (CLAD) is the leading cause of poor long-term survival after lung transplantation (LT). Systems prediction of Chronic Lung Allograft Dysfunction (SysCLAD) aimed to predict CLAD., Methods: To predict CLAD, we investigated the clinicome of patients with LT; the exposome through assessment of airway microbiota in bronchoalveolar lavage cells and air pollution studies; the immunome with works on activation of dendritic cells, the role of T cells to promote the secretion of matrix metalloproteinase-9, and subpopulations of T and B cells; genome polymorphisms; blood transcriptome; plasma proteome studies and assessment of MSK1 expression., Results: Clinicome: the best multivariate logistic regression analysis model for early-onset CLAD in 422 LT eligible patients generated a ROC curve with an area under the curve of 0.77. Exposome: chronic exposure to air pollutants appears deleterious on lung function levels in LT recipients (LTRs), might be modified by macrolides, and increases mortality. Our findings established a link between the lung microbial ecosystem, human lung function, and clinical stability post-transplant. Immunome: a decreased expression of CLEC1A in human lung transplants is predictive of the development of chronic rejection and associated with a higher level of interleukin 17A; Immune cells support airway remodeling through the production of plasma MMP-9 levels, a potential predictive biomarker of CLAD. Blood CD9-expressing B cells appear to favor the maintenance of long-term stable graft function and are a potential new predictive biomarker of BOS-free survival. An early increase of blood CD4 + CD57 + ILT2+ T cells after LT may be associated with CLAD onset. Genome: Donor Club cell secretory protein G38A polymorphism is associated with a decreased risk of severe primary graft dysfunction after LT. Transcriptome: blood POU class 2 associating factor 1, T-cell leukemia/lymphoma domain, and B cell lymphocytes, were validated as predictive biomarkers of CLAD phenotypes more than 6 months before diagnosis. Proteome: blood A2MG is an independent predictor of CLAD, and MSK1 kinase overexpression is either a marker or a potential therapeutic target in CLAD., Conclusion: Systems prediction of Chronic Lung Allograft Dysfunction generated multiple fingerprints that enabled the development of predictors of CLAD. These results open the way to the integration of these fingerprints into a predictive handprint., Competing Interests: The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest., (Copyright © 2023 Pison, Tissot, Bernasconi, Royer, Roux, Koutsokera, Coiffard, Renaud-Picard, Le Pavec, Mordant, Demant, Villeneuve, Mornex, Nemska, Frossard, Brugière, Siroux, Marsland, Foureau, Botturi, Durand, Pellet, Danger, Auffray, Brouard, Nicod, Magnan and Members of the COhort of Lung Transplantation and Systems prediction of Chronic Lung Allograft Dysfunction consortia.)
- Published
- 2023
- Full Text
- View/download PDF
16. Age matters: Microbiome depletion prior to repeat mild traumatic brain injury differentially alters microbial composition and function in adolescent and adult rats.
- Author
-
Sgro M, Iacono G, Yamakawa GR, Kodila ZN, Marsland BJ, and Mychasiuk R
- Subjects
- Rats, Animals, Rats, Sprague-Dawley, Anti-Bacterial Agents pharmacology, Brain Concussion, Microbiota, Gastrointestinal Microbiome, Tenericutes
- Abstract
Dysregulation of the gut microbiome has been shown to perpetuate neuroinflammation, alter intestinal permeability, and modify repetitive mild traumatic brain injury (RmTBI)-induced deficits. However, there have been no investigations regarding the comparative effects that the microbiome may have on RmTBI in adolescents and adults. Therefore, we examined the influence of microbiome depletion prior to RmTBI on microbial composition and metabolome, in adolescent and adult Sprague Dawley rats. Rats were randomly assigned to standard or antibiotic drinking water for 14 days, and to subsequent sham or RmTBIs. The gut microbiome composition and metabolome were analysed at baseline, 1 day after the first mTBI, and at euthanasia (11 days following the third mTBI). At euthanasia, intestinal samples were also collected to quantify tight junction protein (TJP1 and occludin) expression. Adolescents were significantly more susceptible to microbiome depletion via antibiotic administration which increased pro-inflammatory composition and metabolites. Furthermore, RmTBI induced a transient increase in 'beneficial bacteria' (Lachnospiraceae and Faecalibaculum) in only adolescents that may indicate compensatory action in response to the injury. Finally, microbiome depletion prior to RmTBI generated a microbiome composition and metabolome that exemplified a potentially chronic pathogenic and inflammatory state as demonstrated by increased Clostridium innocuum and Erysipelatoclostridium and reductions in Bacteroides and Clostridium Sensu Stricto. Results highlight that adolescents are more vulnerable to RmTBI compared to adults and dysbiosis prior to injury may exacerbate secondary inflammatory cascades., Competing Interests: The authors declare no competing interests exist., (Copyright: © 2022 Sgro et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.)
- Published
- 2022
- Full Text
- View/download PDF
17. Adding data to gut feelings.
- Author
-
Marsland BJ and Harris NL
- Subjects
- Humans, Pain, Inflammation, Emotions, Neuropeptides, Gastrointestinal Microbiome
- Abstract
Pain-sensing neurons detect environmental insults and tissue injury, driving avoidance behavior and the local release of neuropeptides. Two related papers in this issue of Cell report that gut-innervating pain neurons sense bacterial presence to both shape the constituents of the gut microbiome and protect against excessive inflammation., Competing Interests: Declaration of interests The authors declare no competing interests., (Crown Copyright © 2022. Published by Elsevier Inc. All rights reserved.)
- Published
- 2022
- Full Text
- View/download PDF
18. Strain-specific impacts of probiotics are a significant driver of gut microbiome development in very preterm infants.
- Author
-
Beck LC, Masi AC, Young GR, Vatanen T, Lamb CA, Smith R, Coxhead J, Butler A, Marsland BJ, Embleton ND, Berrington JE, and Stewart CJ
- Subjects
- Anti-Bacterial Agents, Bifidobacterium genetics, Female, Humans, Infant, Infant, Newborn, Infant, Premature, Bifidobacterium bifidum, Gastrointestinal Microbiome, Probiotics
- Abstract
The development of the gut microbiome from birth plays important roles in short- and long-term health, but factors influencing preterm gut microbiome development are poorly understood. In the present study, we use metagenomic sequencing to analyse 1,431 longitudinal stool samples from 123 very preterm infants (<32 weeks' gestation) who did not develop intestinal disease or sepsis over a study period of 10 years. During the study period, one cohort had no probiotic exposure whereas two cohorts were given different probiotic products: Infloran (Bifidobacterium bifidum and Lactobacillus acidophilus) or Labinic (B. bifidum, B. longum subsp. infantis and L. acidophilus). Mothers' own milk, breast milk fortifier, antibiotics and probiotics were significantly associated with the gut microbiome, with probiotics being the most significant factor. Probiotics drove microbiome transition into different preterm gut community types (PGCTs), each enriched in a different Bifidobacterium sp. and significantly associated with increased postnatal age. Functional analyses identified stool metabolites associated with PGCTs and, in preterm-derived organoids, sterile faecal supernatants impacted intestinal, organoid monolayer, gene expression in a PGCT-specific manner. The present study identifies specific influencers of gut microbiome development in very preterm infants, some of which overlap with those impacting term infants. The results highlight the importance of strain-specific differences in probiotic products and their impact on host interactions in the preterm gut., (© 2020. The Author(s).)
- Published
- 2022
- Full Text
- View/download PDF
19. Gut-derived short-chain fatty acids modulate skin barrier integrity by promoting keratinocyte metabolism and differentiation.
- Author
-
Trompette A, Pernot J, Perdijk O, Alqahtani RAA, Domingo JS, Camacho-Muñoz D, Wong NC, Kendall AC, Wiederkehr A, Nicod LP, Nicolaou A, von Garnier C, Ubags NDJ, and Marsland BJ
- Subjects
- Allergens, Child, Dietary Fiber, Fatty Acids, Volatile, Humans, Keratinocytes, Dermatitis, Atopic, Food Hypersensitivity
- Abstract
Barrier integrity is central to the maintenance of healthy immunological homeostasis. Impaired skin barrier function is linked with enhanced allergen sensitization and the development of diseases such as atopic dermatitis (AD), which can precede the development of other allergic disorders, for example, food allergies and asthma. Epidemiological evidence indicates that children suffering from allergies have lower levels of dietary fibre-derived short-chain fatty acids (SCFA). Using an experimental model of AD-like skin inflammation, we report that a fermentable fibre-rich diet alleviates systemic allergen sensitization and disease severity. The gut-skin axis underpins this phenomenon through SCFA production, particularly butyrate, which strengthens skin barrier function by altering mitochondrial metabolism of epidermal keratinocytes and the production of key structural components. Our results demonstrate that dietary fibre and SCFA improve epidermal barrier integrity, ultimately limiting early allergen sensitization and disease development.The Graphical Abstract was designed using Servier Medical Art images ( https://smart.servier.com )., (© 2022. The Author(s).)
- Published
- 2022
- Full Text
- View/download PDF
20. The lung-brain axis: A new frontier in host-microbe interactions.
- Author
-
Azzoni R and Marsland BJ
- Subjects
- Brain, Host Microbial Interactions, Lung, Gastrointestinal Microbiome, Microbiota physiology
- Abstract
The gut microbiome is well-known to shape local and distal immune responses, both in health and disease. In a recent issue of Nature, Hosang et al. demonstrate how the lung microbiome regulates the magnitude of autoimmune inflammation in the brain., (Copyright © 2022 Elsevier Inc. All rights reserved.)
- Published
- 2022
- Full Text
- View/download PDF
21. Early life inter-kingdom interactions shape the immunological environment of the airways.
- Author
-
Pattaroni C, Macowan M, Chatzis R, Daunt C, Custovic A, Shields MD, Power UF, Grigg J, Roberts G, Ghazal P, Schwarze J, Gore M, Turner S, Bush A, Saglani S, Lloyd CM, and Marsland BJ
- Subjects
- Bacteria, Humans, Infant, Newborn, Oropharynx immunology, Oropharynx microbiology, Prospective Studies, Respiratory System immunology, Respiratory System microbiology, Microbiota genetics, Microbiota immunology
- Abstract
Background: There is increasing evidence that the airway microbiome plays a key role in the establishment of respiratory health by interacting with the developing immune system early in life. While it has become clear that bacteria are involved in this process, there is a knowledge gap concerning the role of fungi. Moreover, the inter-kingdom interactions that influence immune development remain unknown. In this prospective exploratory human study, we aimed to determine early post-natal microbial and immunological features of the upper airways in 121 healthy newborns., Results: We found that the oropharynx and nasal cavity represent distinct ecological niches for bacteria and fungi. Breastfeeding correlated with changes in microbiota composition of oropharyngeal samples with the greatest impact upon the relative abundance of Streptococcus species and Candida. Host transcriptome profiling revealed that genes with the highest expression variation were immunological in nature. Multi-omics factor analysis of host and microbial data revealed unique co-variation patterns., Conclusion: These data provide evidence of a diverse multi-kingdom microbiota linked with local immunological characteristics in the first week of life that could represent distinct trajectories for future respiratory health., Trial Registration: NHS Health Research Authority, IRAS ID 199053. Registered 5 Oct 2016. https://www.hra.nhs.uk/planning-and-improving-research/application-summaries/research-summaries/breathing-together/ Video abstract., (© 2022. The Author(s).)
- Published
- 2022
- Full Text
- View/download PDF
22. Multi-omics profiling predicts allograft function after lung transplantation.
- Author
-
Watzenboeck ML, Gorki AD, Quattrone F, Gawish R, Schwarz S, Lambers C, Jaksch P, Lakovits K, Zahalka S, Rahimi N, Starkl P, Symmank D, Artner T, Pattaroni C, Fortelny N, Klavins K, Frommlet F, Marsland BJ, Hoetzenecker K, Widder S, and Knapp S
- Subjects
- Allografts, Cohort Studies, Humans, Lung, RNA, Ribosomal, 16S genetics, Retrospective Studies, Lung Transplantation, Microbiota
- Abstract
Rationale: Lung transplantation is the ultimate treatment option for patients with end-stage respiratory diseases but bears the highest mortality rate among all solid organ transplantations due to chronic lung allograft dysfunction (CLAD). The mechanisms leading to CLAD remain elusive due to an insufficient understanding of the complex post-transplant adaptation processes., Objectives: To better understand these lung adaptation processes after transplantation and to investigate their association with future changes in allograft function., Methods: We performed an exploratory cohort study of bronchoalveolar lavage samples from 78 lung recipients and donors. We analysed the alveolar microbiome using 16S rRNA sequencing, the cellular composition using flow cytometry, as well as metabolome and lipidome profiling., Measurements and Main Results: We established distinct temporal dynamics for each of the analysed data sets. Comparing matched donor and recipient samples, we revealed that recipient-specific as well as environmental factors, rather than the donor microbiome, shape the long-term lung microbiome. We further discovered that the abundance of certain bacterial strains correlated with underlying lung diseases even after transplantation. A decline in forced expiratory volume during the first second (FEV
1 ) is a major characteristic of lung allograft dysfunction in transplant recipients. By using a machine learning approach, we could accurately predict future changes in FEV1 from our multi-omics data, whereby microbial profiles showed a particularly high predictive power., Conclusion: Bronchoalveolar microbiome, cellular composition, metabolome and lipidome show specific temporal dynamics after lung transplantation. The lung microbiome can predict future changes in lung function with high precision., Competing Interests: Conflict of interest: M.L. Watzenböck has nothing to disclose. Conflict of interest: A.-D. Gorki has nothing to disclose. Conflict of interest: F. Quattrone has nothing to disclose. Conflict of interest: R. Gawish has nothing to disclose. Conflict of interest: S. Schwarz has nothing to disclose. Conflict of interest: C. Lambers has nothing to disclose. Conflict of interest: P. Jaksch has nothing to disclose. Conflict of interest: K. Lakovits has nothing to disclose. Conflict of interest: S. Zahalka has nothing to disclose. Conflict of interest: N. Rahimi has nothing to disclose. Conflict of interest: P. Starkl has nothing to disclose. Conflict of interest: D. Symmank has nothing to disclose. Conflict of interest: T. Artner has nothing to disclose. Conflict of interest: C. Pattaroni has nothing to disclose. Conflict of interest: N. Fortelny has nothing to disclose. Conflict of interest: K. Klavins has nothing to disclose. Conflict of interest: F. Frommlet has nothing to disclose. Conflict of interest: B.J. Marsland has nothing to disclose. Conflict of interest: K. Hoetzenecker has nothing to disclose. Conflict of interest: S. Widder reports grants from Austrian Science Fund (Elise Richter V585-B31), during the conduct of the study. Conflict of interest: S. Knapp reports grants from FWF, during the conduct of the study., (Copyright ©The authors 2022. For reproduction rights and permissions contact permissions@ersnet.org.)- Published
- 2022
- Full Text
- View/download PDF
23. Protection against allergies: Microbes, immunity, and the farming effect.
- Author
-
Deckers J, Marsland BJ, and von Mutius E
- Subjects
- Adaptive Immunity, Age Factors, Agriculture, Animals, Disease Management, Disease Susceptibility immunology, Environmental Exposure, Host-Pathogen Interactions immunology, Humans, Hypersensitivity diagnosis, Hypersensitivity prevention & control, Immunity, Innate, Microbiota immunology, Hypersensitivity etiology, Hypersensitivity therapy
- Abstract
The prevalence of asthma and other allergic diseases has rapidly increased in "Westernized" countries over recent decades. This rapid increase suggests the involvement of environmental factors, behavioral changes or lifestyle, rather than genetic drift. It has become increasingly clear that the microbiome plays a key role in educating the host immune system and, thus, regulation of disease susceptibility. This review will focus on recent advances uncovering immunological and microbial mechanisms that protect against allergies, in particular, within the context of a farming environment. A whole body of epidemiological data disclosed the nature of the protective exposures in a farm. Current evidence points toward an important role of the host microbiome in setting an immunological equilibrium that determines progression toward, or protection against allergic diseases. Conclusive mechanistic insights on how microbial exposures prevent from developing allergic diseases in humans are still lacking but findings from experimental models reveal plausible immunological mechanisms. Gathering further knowledge on these mechanisms and confirming their relevance in humans is of great importance to develop preventive strategies for children at risk of developing allergies., (© 2021 Wiley-VCH GmbH.)
- Published
- 2021
- Full Text
- View/download PDF
24. Of bats and men: Immunomodulatory treatment options for COVID-19 guided by the immunopathology of SARS-CoV-2 infection.
- Author
-
Christie MJ, Irving AT, Forster SC, Marsland BJ, Hansbro PM, Hertzog PJ, Nold-Petry CA, and Nold MF
- Subjects
- Animals, Antibodies, Neutralizing immunology, COVID-19 virology, Humans, COVID-19 immunology, Chiroptera immunology, Chiroptera virology, Immunologic Factors immunology, SARS-CoV-2 immunology
- Abstract
In humans, SARS-CoV-2 (severe acute respiratory syndrome coronavirus 2) is highly infective, often causes severe acute and/or long-term illness, and elicits a high rate of mortality, even in countries with sophisticated medical systems. Detailed knowledge on the immune responses underpinning COVID-19 (coronavirus disease 2019), and on strategies SARS-CoV-2 uses to evade them, can provide pivotal guidance to researchers and clinicians developing and administering potentially life-saving immunomodulatory therapies. The need for such therapies in COVID-19 is unlikely to abate soon given the emergence of variants of concern that may pose new challenges for some vaccines and neutralizing antibodies. Here, we summarize current knowledge on COVID-19 immunopathogenesis in relation to three clinical disease stages and focus on immune evasion strategies used by pathogenic coronaviruses such as skewing type I, II, and III interferon responses and inhibiting detection via pattern recognition and antigen presentation. Insights gained from bats, which exhibit minimal disease in response to SARS-CoV-2 infection, offer an informative perspective and may guide future development of new therapies. We also discuss how knowledge of immunopathology may inform therapeutic decisions, for example, on selecting the most appropriate immunotherapeutic agents and timing their administration, to reduce morbidity and mortality of COVID-19.
- Published
- 2021
- Full Text
- View/download PDF
25. A prevalent and culturable microbiota links ecological balance to clinical stability of the human lung after transplantation.
- Author
-
Das S, Bernasconi E, Koutsokera A, Wurlod DA, Tripathi V, Bonilla-Rosso G, Aubert JD, Derkenne MF, Mercier L, Pattaroni C, Rapin A, von Garnier C, Marsland BJ, Engel P, and Nicod LP
- Subjects
- Adult, Allografts immunology, Allografts microbiology, Bacteria genetics, Bacteria immunology, Bacteria isolation & purification, Bacteria pathogenicity, Bacterial Load immunology, Bacteriological Techniques, Bronchoalveolar Lavage Fluid microbiology, Bronchoscopy, DNA, Bacterial isolation & purification, Female, Graft Rejection diagnosis, Graft Rejection immunology, Humans, Immune Tolerance, Longitudinal Studies, Lung immunology, Male, Metagenomics, Microbiota genetics, Middle Aged, Pneumonia, Bacterial diagnosis, Pneumonia, Bacterial immunology, Prospective Studies, RNA, Ribosomal, 16S genetics, Graft Rejection microbiology, Lung microbiology, Lung Transplantation adverse effects, Microbiota immunology, Pneumonia, Bacterial microbiology
- Abstract
There is accumulating evidence that the lower airway microbiota impacts lung health. However, the link between microbial community composition and lung homeostasis remains elusive. We combine amplicon sequencing and bacterial culturing to characterize the viable bacterial community in 234 longitudinal bronchoalveolar lavage samples from 64 lung transplant recipients and establish links to viral loads, host gene expression, lung function, and transplant health. We find that the lung microbiota post-transplant can be categorized into four distinct compositional states, 'pneumotypes'. The predominant 'balanced' pneumotype is characterized by a diverse bacterial community with moderate viral loads, and host gene expression profiles suggesting immune tolerance. The other three pneumotypes are characterized by being either microbiota-depleted, or dominated by potential pathogens, and are linked to increased immune activity, lower respiratory function, and increased risks of infection and rejection. Collectively, our findings establish a link between the lung microbial ecosystem, human lung function, and clinical stability post-transplant.
- Published
- 2021
- Full Text
- View/download PDF
26. Microbiome-induced antigen-presenting cell recruitment coordinates skin and lung allergic inflammation.
- Author
-
Ubags ND, Trompette A, Pernot J, Nibbering B, Wong NC, Pattaroni C, Rapin A, Nicod LP, Harris NL, and Marsland BJ
- Subjects
- Animals, Antigens, Dermatophagoides immunology, Cell Movement, Chemokines metabolism, Disease Models, Animal, Female, Germ-Free Life, Humans, Hypersensitivity microbiology, Inflammation microbiology, Interleukin-17 metabolism, Male, Mice, Mice, Inbred BALB C, Pyroglyphidae, Antigen-Presenting Cells immunology, Hypersensitivity immunology, Inflammation immunology, Lung immunology, Microbiota immunology, Skin immunology, Th2 Cells immunology
- Abstract
Background: Allergic skin inflammation often presents in early childhood; however, little is known about the events leading to its initiation and whether it is transient or long-term in nature., Objective: We sought to determine the immunologic rules that govern skin inflammation in early life., Methods: Neonatal and adult mice were epicutaneously sensitized with allergen followed by airway allergen challenge. Epicutaneous application of labeled allergen allowed for determination of antigen uptake and processing by antigen-presenting cells. RNAseq and microbiome analysis was performed on skin from neonatal and adult specific pathogen-free and germ-free mice., Results: A mixed T
H 2/TH 17 inflammatory response in the skin and the lungs of adult mice was observed following sensitization and challenge. Comparatively, neonatal mice did not develop overt skin inflammation, but exhibited systemic release of IL-17a and a TH 2-dominated lung response. Mechanical skin barrier disruption was not sufficient to drive allergic skin inflammation, although it did promote systemic immune priming. Skin of neonatal mice and adult germ-free mice was seeded with low numbers of antigen-presenting cells and impaired chemokine and alarmin production. Enhanced chemokine and alarmin production, and seeding of the skin with antigen-presenting cells capable of instructing recruited cells to elicit their effector function, was, at least in part, dependent on formation of the microbiome, and consequently contributed to the development of overt skin disease., Conclusions: These data shed light on the principles that underlie allergic inflammation in different tissues and highlight a window of opportunity that might exist for early-life prevention of allergic diseases., (Copyright © 2020 American Academy of Allergy, Asthma & Immunology. Published by Elsevier Inc. All rights reserved.)- Published
- 2021
- Full Text
- View/download PDF
27. Microbial metabolism of L-tyrosine protects against allergic airway inflammation.
- Author
-
Wypych TP, Pattaroni C, Perdijk O, Yap C, Trompette A, Anderson D, Creek DJ, Harris NL, and Marsland BJ
- Subjects
- Administration, Oral, Allergens, Animals, Antibodies immunology, Antibody Diversity, Bacteria immunology, Cells, Cultured, Chemokine CCL20 metabolism, Coculture Techniques, Cresols administration & dosage, Disease Models, Animal, ErbB Receptors metabolism, Female, Host-Pathogen Interactions, Injections, Intravenous, Lung immunology, Lung pathology, Male, Mice, Inbred C57BL, Mice, Transgenic, Pneumonia immunology, Pneumonia metabolism, Pneumonia microbiology, Respiratory Hypersensitivity immunology, Respiratory Hypersensitivity metabolism, Respiratory Hypersensitivity microbiology, Signal Transduction, Sulfuric Acid Esters administration & dosage, Toll-Like Receptor 4 metabolism, Tyrosine administration & dosage, Mice, Antibodies metabolism, Bacteria metabolism, Cresols metabolism, Gastrointestinal Microbiome, Intestines microbiology, Lung metabolism, Pneumonia prevention & control, Respiratory Hypersensitivity prevention & control, Sulfuric Acid Esters metabolism, Tyrosine metabolism
- Abstract
The constituents of the gut microbiome are determined by the local habitat, which itself is shaped by immunological pressures, such as mucosal IgA. Using a mouse model of restricted antibody repertoire, we identified a role for antibody-microbe interactions in shaping a community of bacteria with an enhanced capacity to metabolize L-tyrosine. This model led to increased concentrations of p-cresol sulfate (PCS), which protected the host against allergic airway inflammation. PCS selectively reduced CCL20 production by airway epithelial cells due to an uncoupling of epidermal growth factor receptor (EGFR) and Toll-like receptor 4 (TLR4) signaling. Together, these data reveal a gut microbe-derived metabolite pathway that acts distally on the airway epithelium to reduce allergic airway responses, such as those underpinning asthma.
- Published
- 2021
- Full Text
- View/download PDF
28. Fecal Microbiota Nutrient Utilization Potential Suggests Mucins as Drivers for Initial Gut Colonization of Mother-Child-Shared Bacteria.
- Author
-
Nilsen M, Lokmic A, Angell IL, Lødrup Carlsen KC, Carlsen KH, Haugen G, Hedlin G, Jonassen CM, Marsland BJ, Nordlund B, Rehbinder EM, Saunders CM, Skjerven HO, Snipen L, Staff AC, Söderhäll C, Vettukattil R, and Rudi K
- Subjects
- Bacteria, Delivery, Obstetric, Female, Humans, Infant, Infant, Newborn, Metagenome, Mothers, Nutrients, Feces microbiology, Gastrointestinal Microbiome, Mother-Child Relations, Mucins
- Abstract
The nutritional drivers for mother-child sharing of bacteria and the corresponding longitudinal trajectory of the infant gut microbiota development are not yet completely settled. We therefore aimed to characterize the mother-child sharing and the inferred nutritional utilization potential for the gut microbiota from a large unselected cohort. We analyzed in depth gut microbiota in 100 mother-child pairs enrolled antenatally from the general population-based Preventing Atopic Dermatitis and Allergies in Children (PreventADALL) cohort. Fecal samples collected at gestational week 18 for mothers and at birth (meconium), 3, 6, and 12 months for infants were analyzed by reduced metagenome sequencing to determine metagenome size and taxonomic composition. The nutrient utilization potential was determined based on the Virtual Metabolic Human (VMH, www.vmh.life) database. The estimated median metagenome size was ∼150 million base pairs (bp) for mothers and ∼20 million bp at birth for the children. Longitudinal analyses revealed mother-child sharing ( P < 0.05, chi-square test) from birth up to 6 months for 3 prevalent Bacteroides species (prevalence, >25% for all age groups). In a multivariate analysis of variance (ANOVA), the mother-child-shared Bacteroides were associated with vaginal delivery (1.7% explained variance, P = 0.0001). Both vaginal delivery and mother-child sharing were associated with host-derived mucins as nutrient sources. The age-related increase in metagenome size corresponded to an increased diversity in nutrient utilization, with dietary polysaccharides as the main age-related factor. Our results support host-derived mucins as potential selection means for mother-child sharing of initial colonizers, while the age-related increase in diversity was associated with dietary polysaccharides. IMPORTANCE The initial bacterial colonization of human infants is crucial for lifelong health. Understanding the factors driving this colonization will therefore be of great importance. Here, we used a novel high-taxonomic-resolution approach to deduce the nutrient utilization potential of the infant gut microbiota in a large longitudinal mother-child cohort. We found mucins as potential selection means for the initial colonization of mother-child-shared bacteria, while the transition to a more adult-like microbiota was associated with dietary polysaccharide utilization potential. This knowledge will be important for a future understanding of the importance of diet in shaping the gut microbiota composition and development during infancy., (Copyright © 2021 American Society for Microbiology.)
- Published
- 2021
- Full Text
- View/download PDF
29. An anti-inflammatory eicosanoid switch mediates the suppression of type-2 inflammation by helminth larval products.
- Author
-
de Los Reyes Jiménez M, Lechner A, Alessandrini F, Bohnacker S, Schindela S, Trompette A, Haimerl P, Thomas D, Henkel F, Mourão A, Geerlof A, da Costa CP, Chaker AM, Brüne B, Nüsing R, Jakobsson PJ, Nockher WA, Feige MJ, Haslbeck M, Ohnmacht C, Marsland BJ, Voehringer D, Harris NL, Schmidt-Weber CB, and Esser-von Bieren J
- Subjects
- Animals, Anti-Inflammatory Agents, Cyclooxygenase 2, Humans, Inflammation, Larva, Mice, Eicosanoids, Helminths
- Abstract
Eicosanoids are key mediators of type-2 inflammation, e.g., in allergy and asthma. Helminth products have been suggested as remedies against inflammatory diseases, but their effects on eicosanoids are unknown. Here, we show that larval products of the helminth Heligmosomoides polygyrus bakeri ( HpbE ), known to modulate type-2 responses, trigger a broad anti-inflammatory eicosanoid shift by suppressing the 5-lipoxygenase pathway, but inducing the cyclooxygenase (COX) pathway. In human macrophages and granulocytes, the HpbE -driven induction of the COX pathway resulted in the production of anti-inflammatory mediators [e.g., prostaglandin E
2 (PGE2 ) and IL-10] and suppressed chemotaxis. HpbE also abrogated the chemotaxis of granulocytes from patients suffering from aspirin-exacerbated respiratory disease (AERD), a severe type-2 inflammatory condition. Intranasal treatment with HpbE extract attenuated allergic airway inflammation in mice, and intranasal transfer of HpbE -conditioned macrophages led to reduced airway eosinophilia in a COX/PGE2 -dependent fashion. The induction of regulatory mediators in macrophages depended on p38 mitogen-activated protein kinase (MAPK), hypoxia-inducible factor-1α (HIF-1α), and Hpb glutamate dehydrogenase (GDH), which we identify as a major immunoregulatory protein in HpbE Hpb GDH activity was required for anti-inflammatory effects of HpbE in macrophages, and local administration of recombinant Hpb GDH to the airways abrogated allergic airway inflammation in mice. Thus, a metabolic enzyme present in helminth larvae can suppress type-2 inflammation by inducing an anti-inflammatory eicosanoid switch, which has important implications for the therapy of allergy and asthma., (Copyright © 2020 The Authors, some rights reserved; exclusive licensee American Association for the Advancement of Science. No claim to original U.S. Government Works.)- Published
- 2020
- Full Text
- View/download PDF
30. Skin emollient and early complementary feeding to prevent infant atopic dermatitis (PreventADALL): a factorial, multicentre, cluster-randomised trial.
- Author
-
Skjerven HO, Rehbinder EM, Vettukattil R, LeBlanc M, Granum B, Haugen G, Hedlin G, Landrø L, Marsland BJ, Rudi K, Sjøborg KD, Söderhäll C, Staff AC, Carlsen KH, Asarnoj A, Bains KES, Carlsen OCL, Endre KMA, Granlund PA, Hermansen JU, Gudmundsdóttir HK, Hilde K, Håland G, Kreyberg I, Olsen IC, Mägi CO, Nordhagen LS, Saunders CM, Skrindo I, Tedner SG, Værnesbranden MR, Wiik J, Jonassen CM, Nordlund B, and Carlsen KCL
- Subjects
- Administration, Topical, Cluster Analysis, Dermatitis, Atopic therapy, Dermatologic Agents therapeutic use, Female, Hospitals, University, Humans, Infant, Infant, Newborn, Male, Norway, Prospective Studies, Risk Factors, Sweden, Treatment Outcome, Dermatitis, Atopic prevention & control, Emollients therapeutic use, Food Hypersensitivity prevention & control, Infant Nutritional Physiological Phenomena
- Abstract
Background: Skin emollients applied during early infancy could prevent atopic dermatitis, and early complementary food introduction might reduce food allergy in high-risk infants. The study aimed to determine if either regular skin emollients applied from 2 weeks of age, or early complementary feeding introduced between 12 and 16 weeks of age, reduced development of atopic dermatitis by age 12 months in the general infant population., Methods: This population-based 2×2 factorial, randomised clinical trial was done at Oslo University Hospital and Østfold Hospital Trust, Oslo, Norway; and Karolinska University Hospital, Stockholm, Sweden. Infants of women recruited antenatally at the routine ultrasound pregnancy screening at 18 weeks were cluster-randomised at birth from 2015 to 2017 to the following groups: (1) controls with no specific advice on skin care while advised to follow national guidelines on infant nutrition (no intervention group); (2) skin emollients (bath additives and facial cream; skin intervention group); (3) early complementary feeding of peanut, cow's milk, wheat, and egg (food intervention group); or (4) combined skin and food interventions (combined intervention group). Participants were randomly assigned (1:1:1:1) using computer- generated cluster randomisation based on 92 geographical living area blocks as well as eight 3-month time blocks. Carers were instructed to apply the interventions on at least 4 days per week. Atopic dermatitis by age 12 months was the primary outcome, based on clinical investigations at 3, 6 and 12 months by investigators masked to group allocation. Atopic dermatitis was assessed after completing the 12-month investigations and diagnosed if either of the UK Working Party and Hanifin and Rajka (12 months only) diagnostic criteria were fulfilled. The primary efficacy analyses was done by intention-to-treat analysis on all randomly assigned participants. Food allergy results will be reported once all investigations at age 3 years are completed in 2020. This was a study performed within ORAACLE (the Oslo Research Group of Asthma and Allergy in Childhood; the Lung and Environment). The study is registered at clinicaltrials.gov, NCT02449850., Findings: 2697 women were recruited between Dec 9, 2014, and Oct 31, 2016, from whom 2397 newborn infants were enrolled from April 14, 2015, to April 11, 2017. Atopic dermatitis was observed in 48 (8%) of 596 infants in the no intervention group, 64 (11%) of 575 in the skin intervention group, 58 (9%) of 642 in the food intervention group, and 31 (5%) of 583 in the combined intervention group. Neither skin emollients nor early complementary feeding reduced development of atopic dermatitis, with a risk difference of 3·1% (95% CI -0·3 to 6·5) for skin intervention and 1·0% (-2·1 to 4·1) for food intervention, in favour of control. No safety concerns with the interventions were identified. Reported skin symptoms and signs (including itching, oedema, exanthema, dry skin, and urticaria) were no more frequent in the skin, food, and combined intervention groups than in the no intervention group., Interpretation: Neither early skin emollients nor early complementary feeding reduced development of atopic dermatitis by age 12 months. Our study does not support the use of these interventions to prevent atopic dermatitis by 12 months of age in infants., Funding: The study was funded by several public and private funding bodies: The Regional Health Board South East, The Norwegian Research Council, Health and Rehabilitation Norway, The Foundation for Healthcare and Allergy Research in Sweden-Vårdalstiftelsen, Swedish Asthma and Allergy Association's Research Foundation, Swedish Research Council-the Initiative for Clinical Therapy Research, The Swedish Heart-Lung Foundation, SFO-V at the Karolinska Institute, Freemason Child House Foundation in Stockholm, Swedish Research Council for Health, Working Life and Welfare-FORTE, Oslo University Hospital, the University of Oslo, and Østfold Hospital Trust., (Copyright © 2020 Elsevier Ltd. All rights reserved.)
- Published
- 2020
- Full Text
- View/download PDF
31. Infection with a small intestinal helminth, Heligmosomoides polygyrus bakeri, consistently alters microbial communities throughout the murine small and large intestine.
- Author
-
Rapin A, Chuat A, Lebon L, Zaiss MM, Marsland BJ, and Harris NL
- Subjects
- Animals, Host Microbial Interactions, Host-Parasite Interactions, Intestinal Mucosa microbiology, Intestinal Mucosa parasitology, Intestine, Large microbiology, Intestine, Large parasitology, Metagenomics, Mice, Peptostreptococcus growth & development, Gastrointestinal Microbiome, Helminthiasis, Intestinal Diseases, Parasitic, Intestines microbiology, Intestines parasitology, Nematospiroides dubius microbiology, Nematospiroides dubius parasitology
- Abstract
Increasing evidence suggests that intestinal helminth infection can alter intestinal microbial communities with important impacts on the mammalian host. However, all of the studies to date utilize different techniques to study the microbiome and access different sites of the intestine with little consistency noted between studies. In the present study, we set out to perform a comprehensive analysis of the impact of intestinal helminth infection on the mammalian intestinal bacterial microbiome. For this purpose, we investigated the impact of experimental infection using the natural murine small intestinal helminth, Heligmosomoides polygyrus bakeri and examined possible alterations in both the mucous and luminal bacterial communities along the entire small and large intestine. We also explored the impact of common experimental variables including the parasite batch and pre-infection microbiome, on the outcome of helminth-bacterial interactions. This work provides evidence that helminth infection reproducibly alters intestinal microbial communities, with an impact of infection noted along the entire length of the intestine. Although the exact nature of helminth-induced alterations to the intestinal microbiome differed depending on the microbiome community structure present prior to infection, changes extended well beyond the introduction of new bacterial species by the infecting larvae. Moreover, striking similarities between different experiments were noted, including the consistent outgrowth of a bacterium belonging to the Peptostreptococcaceae family throughout the intestine., (Copyright © 2019 Australian Society for Parasitology. Published by Elsevier Ltd. All rights reserved.)
- Published
- 2020
- Full Text
- View/download PDF
32. The microbiome: toward preventing allergies and asthma by nutritional intervention.
- Author
-
Perdijk O and Marsland BJ
- Subjects
- Asthma immunology, Gastrointestinal Microbiome genetics, Gastrointestinal Microbiome immunology, Humans, Hypersensitivity immunology, Asthma prevention & control, Gastrointestinal Microbiome physiology, Hypersensitivity prevention & control, Nutritional Status immunology
- Abstract
Allergies and asthma have increased in prevalence over recent decades while the development of therapies to treat or prevent them has stagnated. Genetic predisposition and lifestyle changes influence the constituents of the microbiome and these host-environment-microbe interactions represent a key underlying pressure influencing disease susceptibility. Consequently, there has been a surge of interest in shaping the microbiome to a health-promoting state particularly through nutritional intervention strategies. However, mechanistic insights into the nutrition-microbe-host interplay are still needed in order for such approaches to succeed. In addition, little is known about how trans-kingdom interactions might influence disease susceptibility and progression. Future steps toward revealing the underlying mechanisms of host-microbe interactions will be pivotal for the development of effective dietary intervention strategies for the prevention and treatment of allergic diseases., (Copyright © 2019. Published by Elsevier Ltd.)
- Published
- 2019
- Full Text
- View/download PDF
33. The influence of the microbiome on respiratory health.
- Author
-
Wypych TP, Wickramasinghe LC, and Marsland BJ
- Subjects
- Acinetobacter, Animals, Bifidobacterium, Dietary Supplements, Female, Host-Pathogen Interactions, Humans, Lactobacillus, Lung immunology, Lung Diseases diet therapy, Lung Diseases immunology, Maternal Exposure, Pregnancy, Gastrointestinal Microbiome, Lung microbiology, Lung Diseases microbiology, Microbiota, Probiotics therapeutic use
- Abstract
The revolution in microbiota research over the past decade has provided invaluable knowledge about the function of the microbial species that inhabit the human body. It has become widely accepted that these microorganisms, collectively called 'the microbiota', engage in networks of interactions with each other and with the host that aim to benefit both the microbial members and the mammalian members of this unique ecosystem. The lungs, previously thought to be sterile, are now known to harbor a unique microbiota and, additionally, to be influenced by microbial signals from distal body sites, such as the intestine. Here we review the role of the lung and gut microbiotas in respiratory health and disease and highlight the main pathways of communication that underlie the gut-lung axis.
- Published
- 2019
- Full Text
- View/download PDF
34. Microbes, metabolites, and the gut-lung axis.
- Author
-
Dang AT and Marsland BJ
- Subjects
- Animals, Bone Marrow, Dysbiosis, Fatty Acids, Volatile metabolism, Gastrointestinal Microbiome immunology, Gastrointestinal Tract immunology, Hematopoiesis, Humans, Immunomodulation, Intestinal Mucosa immunology, Intestinal Mucosa metabolism, Intestinal Mucosa microbiology, Energy Metabolism, Gastrointestinal Tract metabolism, Gastrointestinal Tract microbiology, Homeostasis, Lung physiology, Microbiota
- Abstract
The microbiota plays an essential role in the education, development, and function of the immune system, both locally and systemically. Emerging experimental and epidemiological evidence highlights a crucial cross-talk between the intestinal microbiota and the lungs, termed the 'gut-lung axis'. Changes in the constituents of the gut microbiome, through either diet, disease or medical interventions (such as antibiotics) is linked with altered immune responses and homeostasis in the airways. The importance of the gut-lung axis has become more evident following the identification of several gut microbe-derived components and metabolites, such as short-chain fatty acids (SCFAs), as key mediators for setting the tone of the immune system. Recent studies have supported a role for SCFAs in influencing hematopoietic precursors in the bone marrow-a major site of innate and adaptive immune cell development. Here, we review the current understanding of host-microbe cross-talk along the gut-lung axis. We highlight the importance of SCFAs in shaping and promoting bone marrow hematopoiesis to resolve airway inflammation and to support a healthy homeostasis.
- Published
- 2019
- Full Text
- View/download PDF
35. Lower airway microbiota associates with inflammatory phenotype in severe preschool wheeze.
- Author
-
Robinson PFM, Pattaroni C, Cook J, Gregory L, Alonso AM, Fleming LJ, Lloyd CM, Bush A, Marsland BJ, and Saglani S
- Subjects
- Child, Preschool, Female, Humans, Male, Microbiota, Phenotype, Inflammation immunology, Inflammation microbiology, Lung immunology, Lung microbiology, Respiratory Sounds
- Published
- 2019
- Full Text
- View/download PDF
36. Sperm Microbiota and Its Impact on Semen Parameters.
- Author
-
Baud D, Pattaroni C, Vulliemoz N, Castella V, Marsland BJ, and Stojanov M
- Abstract
Compared to its female counterpart, the microbiota of the male genital tract has not been studied extensively. With this study, we aimed to evaluate the bacterial composition of seminal fluid and its impact on sperm parameters. We hypothesized that a dysbiotic microbiota composition may have an influence on sperm quality. Semen samples of 26 men with normal spermiogram and 68 men with at least one abnormal spermiogram parameter were included in the study. Samples were stratified based on total sperm count, spermatozoa concentration, progressive motility, total motility and spermatozoa morphology. Microbiota profiling was performed using 16S rRNA gene amplicons sequencing and total bacterial load was determined using a panbacterial quantitative PCR. Semen samples broadly clustered into three microbiota profiles: Prevotella -enriched, Lactobacillus -enriched, and polymicrobial. Prevotella -enriched samples had the highest bacterial load ( p < 0.05). Network analysis identified three main co-occurrence modules, among which two contained bacteria commonly found in the vaginal flora. Genera from the same module displayed similar oxygen requirements, arguing for the presence of different ecological niches for bacteria that colonize semen through the passage. Contrary to our hypothesis, shifts in overall microbiota composition (beta-diversity) did not correlate with spermiogram parameters. Similarly, we did not find any difference in microbial richness or diversity (alpha-diversity). Differential abundance testing, however, revealed three specific genera that were significantly enriched or depleted in some of the sperm quality groups ( p < 0.05). Prevotella relative abundance was increased in samples with defective sperm motility while Staphylococcus was increased in the corresponding control group. In addition, we observed an increased relative abundance of Lactobacillus in samples with normal sperm morphology. Our study indicates that overall bacterial content of sperm might not play a major role in male infertility. Although no major shifts in microbiota composition or diversity were found, the differential abundance of specific bacterial genera in the sperm suggests that a small subset of microbes might impact the spermatozoal physiology during sperm transition, more specifically motility and morphology. Further studies are required to challenge this finding and develop potential strategies to induce the formation of a healthy seminal microbiota.
- Published
- 2019
- Full Text
- View/download PDF
37. Make (No) Bones about Butyrate.
- Author
-
Begka C and Marsland BJ
- Subjects
- Animals, CD8-Positive T-Lymphocytes, Mice, Osteogenesis, Signal Transduction, Wnt Proteins, Butyrates, T-Lymphocytes, Regulatory
- Abstract
In this issue of Immunity, Tyagi et al. (2018) report that the microbial metabolite butyrate orchestrates the interplay between regulatory T cells and CD8
+ T cells, increasing Wnt signaling, and promoting bone formation in young mice., (Copyright © 2018 Elsevier Inc. All rights reserved.)- Published
- 2018
- Full Text
- View/download PDF
38. Early-Life Formation of the Microbial and Immunological Environment of the Human Airways.
- Author
-
Pattaroni C, Watzenboeck ML, Schneidegger S, Kieser S, Wong NC, Bernasconi E, Pernot J, Mercier L, Knapp S, Nicod LP, Marsland CP, Roth-Kleiner M, and Marsland BJ
- Subjects
- Cohort Studies, DNA, Bacterial genetics, Female, Gestational Age, Humans, Immunoglobulin A genetics, Immunoglobulin A metabolism, Infant, Infant, Newborn, Interleukin-33 genetics, Interleukin-33 metabolism, Male, Microbiota genetics, Retrospective Studies, DNA, Bacterial immunology, Host Microbial Interactions immunology, Immune System immunology, Immune System microbiology, Microbiota immunology, Respiratory System immunology, Respiratory System microbiology
- Abstract
Crosstalk between immune cells and the microbiota in mucosal tissues can set an individual on a trajectory toward health or disease. Little is known about these early-life events in the human respiratory tract. We examined bacterial colonization and immune system maturation in the lower airways over the first year of life. The lower respiratory tract microbiota forms within the first 2 postnatal months. Within the first weeks, three microbial profiles are evident, broadly distinguished as dysbiotic or diverse, and representing different microbial virulence potentials, including proteolysis of immunoglobulin A (IgA) that is critical for mucosal defense. Delivery mode determines microbiota constituents in preterm, but not term, births. Gestational age is a key determinant of immune maturation, with airway cells progressively increasing expression of proallergic cytokine interleukin-33 and genes linked with IgA. These data reveal microbial and immunological development in human airways, and may inform early-life interventions to prevent respiratory diseases., (Copyright © 2018 Elsevier Inc. All rights reserved.)
- Published
- 2018
- Full Text
- View/download PDF
39. Airway brush cells: Not as "tuft" as you might think.
- Author
-
Bouchery T and Marsland BJ
- Subjects
- Humans, Inflammation, Interleukin-17, Leukotrienes, Diabetes Mellitus, Type 2, Respiratory System
- Abstract
The leukotriene E
4 receptor CysLT3 R regulates expansion of chemosensory brush cells and production of interleukin-25 in the airways., (Copyright © 2018 The Authors, some rights reserved; exclusive licensee American Association for the Advancement of Science. No claim to original U.S. Government Works.)- Published
- 2018
- Full Text
- View/download PDF
40. Preventing Atopic Dermatitis and ALLergies in Children-the PreventADALL study.
- Author
-
Lødrup Carlsen KC, Rehbinder EM, Skjerven HO, Carlsen MH, Fatnes TA, Fugelli P, Granum B, Haugen G, Hedlin G, Jonassen CM, Landrø L, Lunde J, Marsland BJ, Nordlund B, Rudi K, Sjøborg K, Söderhäll C, Staff AC, Vettukattil R, and Carlsen KH
- Subjects
- Adolescent, Adult, Child, Female, Humans, Infant, Infant, Newborn, Longitudinal Studies, Pregnancy, Treatment Outcome, Young Adult, Dermatitis, Atopic prevention & control, Diet, Hypersensitivity prevention & control
- Published
- 2018
- Full Text
- View/download PDF
41. Antibiotics as Instigators of Microbial Dysbiosis: Implications for Asthma and Allergy.
- Author
-
Wypych TP and Marsland BJ
- Subjects
- Animals, Anti-Bacterial Agents pharmacology, Anti-Bacterial Agents therapeutic use, Asthma epidemiology, Disease Models, Animal, Drug Resistance, Bacterial, Humans, Hypersensitivity epidemiology, Immune System cytology, Immune System immunology, Immune System metabolism, Anti-Bacterial Agents adverse effects, Asthma etiology, Dysbiosis drug therapy, Dysbiosis microbiology, Hypersensitivity etiology, Microbiota drug effects
- Abstract
The human body and its resident microbiota form a complex ecosystem, shaped by both inherited and environmental factors. The use of antibiotics represents an extreme example of environmental pressure and can broadly disrupt the microbial landscape. The benefits that antibiotics have brought to modern medicine are unquestionable; however, their overuse comes with consequences, including the potential for secondary infections by opportunistic pathogens and the spread of antibiotic resistance. Here, we discuss the implications of microbial dysbiosis driven by antibiotics, with a focus on potential links with allergy and asthma. We review epidemiological data on humans, as well as mechanistic studies performed in animal models, and highlight gaps in current knowledge, which if addressed, could drive the design of novel therapeutic strategies and improved clinical care., (Copyright © 2018 Elsevier Ltd. All rights reserved.)
- Published
- 2018
- Full Text
- View/download PDF
42. Microbial and host immune factors as drivers of COPD.
- Author
-
Mika M, Nita I, Morf L, Qi W, Beyeler S, Bernasconi E, Marsland BJ, Ott SR, von Garnier C, and Hilty M
- Abstract
Compartmentalisation of the respiratory tract microbiota in patients with different chronic obstructive pulmonary disease (COPD) severity degrees needs to be systematically investigated. In addition, it is unknown if the inflammatory and emphysematous milieux in patients with COPD are associated with changes in the respiratory tract microbiota and host macrophage gene expression. We performed a cross-sectional study to compare non-COPD controls (n=10) to COPD patients (n=32) with different disease severity degrees. Samples (n=187) were obtained from different sites of the upper and lower respiratory tract. Microbiota analyses were performed by 16S ribosomal RNA gene sequencing and host gene expression analyses by quantitative real-time PCR of distinct markers of bronchoalveolar lavage cells. Overall, the microbial communities of severe COPD (Global Initiative for Chronic Obstructive Lung Disease (GOLD) grade 3/4) patients clustered significantly differently to controls and less severe COPD (GOLD 1/2) patients (permutational multivariate ANOVA (MANOVA), p=0.001). However, we could not detect significant associations between the different sampling sites in the lower airways. In addition, the chosen set of host gene expression markers significantly separated COPD GOLD 3/4 patients, and we found correlations between the composition of the microbiota and the host data. In conclusion, this study demonstrates associations between host gene expression and microbiota profiles that may influence the course of COPD., Competing Interests: Conflict of interest: None declared.
- Published
- 2018
- Full Text
- View/download PDF
43. Dietary Fiber Confers Protection against Flu by Shaping Ly6c - Patrolling Monocyte Hematopoiesis and CD8 + T Cell Metabolism.
- Author
-
Trompette A, Gollwitzer ES, Pattaroni C, Lopez-Mejia IC, Riva E, Pernot J, Ubags N, Fajas L, Nicod LP, and Marsland BJ
- Subjects
- Adaptive Immunity drug effects, Adaptive Immunity immunology, Animals, CD8-Positive T-Lymphocytes metabolism, Dietary Fiber administration & dosage, Fatty Acids, Volatile immunology, Fatty Acids, Volatile metabolism, Hematopoiesis drug effects, Humans, Immunity, Innate drug effects, Immunity, Innate immunology, Mice, Inbred BALB C, Mice, Inbred C57BL, Mice, Knockout, Monocytes drug effects, Monocytes metabolism, Protective Agents administration & dosage, Protective Agents pharmacology, Antigens, Ly immunology, CD8-Positive T-Lymphocytes immunology, Dietary Fiber pharmacology, Hematopoiesis immunology, Monocytes immunology, Orthomyxoviridae Infections immunology
- Abstract
Dietary fiber protects against chronic inflammatory diseases by dampening immune responses through short-chain fatty acids (SCFAs). Here we examined the effect of dietary fiber in viral infection, where the anti-inflammatory properties of SCFAs in principle could prevent protective immunity. Instead, we found that fermentable dietary fiber increased survival of influenza-infected mice through two complementary mechanisms. High-fiber diet (HFD)-fed mice exhibited altered bone marrow hematopoiesis, characterized by enhanced generation of Ly6c
- patrolling monocytes, which led to increased numbers of alternatively activated macrophages with a limited capacity to produce the chemokine CXCL1 in the airways. Blunted CXCL1 production reduced neutrophil recruitment to the airways, thus limiting tissue immunopathology during infection. In parallel, diet-derived SCFAs boosted CD8+ T cell effector function by enhancing cellular metabolism. Hence, dietary fermentable fiber and SCFAs set an immune equilibrium, balancing innate and adaptive immunity so as to promote the resolution of influenza infection while preventing immune-associated pathology., (Copyright © 2018 Elsevier Inc. All rights reserved.)- Published
- 2018
- Full Text
- View/download PDF
44. The neonatal window of opportunity-early priming for life.
- Author
-
Renz H, Adkins BD, Bartfeld S, Blumberg RS, Farber DL, Garssen J, Ghazal P, Hackam DJ, Marsland BJ, McCoy KD, Penders J, Prinz I, Verhasselt V, von Mutius E, Weiser JN, Wesemann DR, and Hornef MW
- Subjects
- Environmental Exposure, Homeostasis, Humans, Hypersensitivity immunology, Hypersensitivity prevention & control, Immune System growth & development, Immune Tolerance, Infant, Newborn, Risk Factors, Child Development physiology, Host Microbial Interactions immunology, Hypersensitivity microbiology, Immune System microbiology, Microbiota
- Published
- 2018
- Full Text
- View/download PDF
45. Airway microbiota signals anabolic and catabolic remodeling in the transplanted lung.
- Author
-
Mouraux S, Bernasconi E, Pattaroni C, Koutsokera A, Aubert JD, Claustre J, Pison C, Royer PJ, Magnan A, Kessler R, Benden C, Soccal PM, Marsland BJ, and Nicod LP
- Subjects
- Adult, Extracellular Matrix immunology, Extracellular Matrix pathology, Female, Fibroblasts immunology, Fibroblasts pathology, Humans, Macrophages immunology, Macrophages pathology, Male, Middle Aged, Airway Remodeling immunology, Bacteria classification, Bacteria immunology, Lung immunology, Lung microbiology, Lung pathology, Lung Transplantation, Microbiota immunology, Signal Transduction immunology
- Abstract
Background: Homeostatic turnover of the extracellular matrix conditions the structure and function of the healthy lung. In lung transplantation, long-term management remains limited by chronic lung allograft dysfunction, an umbrella term used for a heterogeneous entity ultimately associated with pathological airway and/or parenchyma remodeling., Objective: This study assessed whether the local cross-talk between the pulmonary microbiota and host cells is a key determinant in the control of lower airway remodeling posttransplantation., Methods: Microbiota DNA and host total RNA were isolated from 189 bronchoalveolar lavages obtained from 116 patients post lung transplantation. Expression of a set of 11 genes encoding either matrix components or factors involved in matrix synthesis or degradation (anabolic and catabolic remodeling, respectively) was quantified by real-time quantitative PCR. Microbiota composition was characterized using 16S ribosomal RNA gene sequencing and culture., Results: We identified 4 host gene expression profiles, among which catabolic remodeling, associated with high expression of metallopeptidase-7, -9, and -12, diverged from anabolic remodeling linked to maximal thrombospondin and platelet-derived growth factor D expression. While catabolic remodeling aligned with a microbiota dominated by proinflammatory bacteria (eg, Staphylococcus, Pseudomonas, and Corynebacterium), anabolic remodeling was linked to typical members of the healthy steady state (eg, Prevotella, Streptococcus, and Veillonella). Mechanistic assays provided direct evidence that these bacteria can impact host macrophage-fibroblast activation and matrix deposition., Conclusions: Host-microbes interplay potentially determines remodeling activities in the transplanted lung, highlighting new therapeutic opportunities to ultimately improve long-term lung transplant outcome., (Copyright © 2017 The Authors. Published by Elsevier Inc. All rights reserved.)
- Published
- 2018
- Full Text
- View/download PDF
46. Gingival Tissue Inflammation Promotes Increased Matrix Metalloproteinase-12 Production by CD200R low Monocyte-Derived Cells in Periodontitis.
- Author
-
Björnfot Holmström S, Clark R, Zwicker S, Bureik D, Kvedaraite E, Bernasconi E, Nguyen Hoang AT, Johannsen G, Marsland BJ, Boström EA, and Svensson M
- Subjects
- Adult, Antigens, Surface biosynthesis, Antigens, Surface genetics, Cell Division, Cells, Cultured, Coculture Techniques, Cyclooxygenase Inhibitors pharmacology, Epithelial Cells metabolism, Fibroblasts metabolism, Flow Cytometry, Gene Expression Regulation, Gingiva pathology, Granulocyte-Macrophage Colony-Stimulating Factor pharmacology, Humans, Inflammation, Keratinocytes metabolism, Matrix Metalloproteinase 12 biosynthesis, Matrix Metalloproteinase 12 genetics, Monocytes pathology, Orexin Receptors, Periodontitis pathology, Pyrazoles pharmacology, Real-Time Polymerase Chain Reaction, Receptors, Cell Surface biosynthesis, Receptors, Cell Surface genetics, Antigens, Surface physiology, Gingiva enzymology, Matrix Metalloproteinase 12 physiology, Monocytes enzymology, Periodontitis enzymology, Receptors, Cell Surface physiology
- Abstract
Irreversible tissue recession in chronic inflammatory diseases is associated with dysregulated immune activation and production of tissue degradative enzymes. In this study, we identified elevated levels of matrix metalloproteinase (MMP)-12 in gingival tissue of patients with the chronic inflammatory disease periodontitis (PD). The source of MMP12 was cells of monocyte origin as determined by the expression of CD14, CD68, and CD64. These MMP12-producing cells showed reduced surface levels of the coinhibitory molecule CD200R. Similarly, establishing a multicellular three-dimensional model of human oral mucosa with induced inflammation promoted MMP12 production and reduced CD200R surface expression by monocyte-derived cells. MMP12 production by monocyte-derived cells was induced by CSF2 rather than the cyclooxygenase-2 pathway, and treatment of monocyte-derived cells with a CD200R ligand reduced CSF2-induced MMP12 production. Further, MMP12-mediated degradation of the extracellular matrix proteins tropoelastin and fibronectin in the tissue model coincided with a loss of Ki-67, a protein strictly associated with cell proliferation. Reduced amounts of tropoelastin were confirmed in gingival tissue from PD patients. Thus, this novel association of the CD200/CD200R pathway with MMP12 production by monocyte-derived cells may play a key role in PD progression and will be important to take into consideration in the development of future strategies to diagnose, treat, and prevent PD., (Copyright © 2017 by The American Association of Immunologists, Inc.)
- Published
- 2017
- Full Text
- View/download PDF
47. The Impact of Diet on Immunity and Respiratory Diseases.
- Author
-
Wypych TP, Marsland BJ, and Ubags NDJ
- Subjects
- Autoimmunity, Disease Susceptibility, Fatty Acids immunology, Humans, Hygiene Hypothesis, Life Style, Lung Diseases immunology, Diet, Western, Dietary Fats, Gastrointestinal Microbiome immunology, Lung Diseases etiology
- Abstract
The Western world has witnessed a tremendous increase in the occurrence of allergy and autoimmunity in the second half of the 20th century. Extensive efforts have been made to explain this phenomenon and various hypotheses have been formulated. Among them, two concepts have attracted the most attention: the "hygiene hypothesis," identifying the reduced exposure to environmental microorganisms as a driving force behind the observed epidemiological trends; and the "diet hypotheses," pointing to the importance of changes in our dietary habits. In this review, we discuss the interplay between the Western diet, microbiota, and inflammatory conditions, with particular emphasis on respiratory diseases. This is followed by an in-depth overview of the immunomodulatory potential of different dietary fatty acids. We conclude by identifying the outstanding questions, which, if answered, could shed further light on the impact of dietary habits on immunity and interconnect it with postulates proposed by the hygiene hypothesis. Linking these two concepts will be an important step towards understanding how Western lifestyle shapes disease susceptibility.
- Published
- 2017
- Full Text
- View/download PDF
48. Enteric helminth-induced type I interferon signaling protects against pulmonary virus infection through interaction with the microbiota.
- Author
-
McFarlane AJ, McSorley HJ, Davidson DJ, Fitch PM, Errington C, Mackenzie KJ, Gollwitzer ES, Johnston CJC, MacDonald AS, Edwards MR, Harris NL, Marsland BJ, Maizels RM, and Schwarze J
- Subjects
- Animals, Antigens, Helminth immunology, Cells, Cultured, Coinfection, Female, Humans, Immunity, Mucosal, Interferon Type I metabolism, Intestines parasitology, Mice, Mice, Inbred BALB C, Mice, Inbred C57BL, Mice, Knockout, Receptor, Interferon alpha-beta genetics, Signal Transduction, Th2 Cells parasitology, Intestines immunology, Lung immunology, Microbiota immunology, Nematospiroides dubius immunology, Respiratory Syncytial Virus Infections immunology, Respiratory Syncytial Viruses immunology, Strongylida Infections immunology, Th2 Cells immunology
- Abstract
Background: Helminth parasites have been reported to have beneficial immunomodulatory effects in patients with allergic and autoimmune conditions and detrimental consequences in patients with tuberculosis and some viral infections. Their role in coinfection with respiratory viruses is not clear., Objective: Here we investigated the effects of strictly enteric helminth infection with Heligmosomoides polygyrus on respiratory syncytial virus (RSV) infection in a mouse model., Methods: A murine helminth/RSV coinfection model was developed. Mice were infected by means of oral gavage with 200 stage 3 H polygyrus larvae. Ten days later, mice were infected intranasally with either RSV or UV-inactivated RSV., Results: H polygyrus-infected mice showed significantly less disease and pulmonary inflammation after RSV infection associated with reduced viral load. Adaptive immune responses, including T
H 2 responses, were not essential because protection against RSV was maintained in Rag1-/- and Il4rα-/- mice. Importantly, H polygyrus infection upregulated expression of type I interferons and interferon-stimulated genes in both the duodenum and lung, and its protective effects were lost in both Ifnar1-/- and germ-free mice, revealing essential roles for type I interferon signaling and microbiota in H polygyrus-induced protection against RSV., Conclusion: These data demonstrate that a strictly enteric helminth infection can have remote protective antiviral effects in the lung through induction of a microbiota-dependent type I interferon response., (Copyright © 2017 American Academy of Allergy, Asthma & Immunology. Published by Elsevier Inc. All rights reserved.)- Published
- 2017
- Full Text
- View/download PDF
49. Mechanistic insight into the function of the microbiome in lung diseases.
- Author
-
Ubags NDJ and Marsland BJ
- Subjects
- Host-Pathogen Interactions, Humans, Lung Diseases immunology, Lung Diseases physiopathology, Lung microbiology, Lung Diseases microbiology, Microbiota
- Abstract
The lung harbours a diverse array of microbes whose dynamic composition is influenced by both host and environmental factors. Thus far, most studies have described the microbial composition of healthy or diseased lungs and provided an overview of the differences between topographical locations within the respiratory tract. However, insight into the functional mechanisms underlying host-microbe interactions and how they might drive lung health and disease are limited. This review provides an overview of the current mechanistic understanding of the microbiome, crosstalk between tissue compartments, and its involvement in respiratory diseases., Competing Interests: Conflict of interest: None declared., (Copyright ©ERS 2017.)
- Published
- 2017
- Full Text
- View/download PDF
50. Microbiota Analysis Using an Illumina MiSeq Platform to Sequence 16S rRNA Genes.
- Author
-
Rapin A, Pattaroni C, Marsland BJ, and Harris NL
- Subjects
- Animals, Humans, Mice, Phylogeny, Polymerase Chain Reaction, Sequence Analysis, DNA, Bacteria classification, High-Throughput Nucleotide Sequencing, Microbiota, RNA, Ribosomal, 16S genetics
- Abstract
The microbiota have been shown to play an important role in diverse biological processes including immunity, metabolism, and digestion. Assessing the exact composition of the microbiota has proven challenging due to the often unknown growth specificities of its members, and culture-based approaches typically fail to capture the complete diversity of microorganisms present. Next Generation Sequencing (NGS) methods provide an efficient means to gather information about cultured and uncultured members of the microbiota. This article provides a method to characterize bacterial communities in terms of species composition using high-throughput sequencing. Briefly, by extracting the entire DNA content of a microbiota sample and performing a targeted high-throughput sequencing of the 16S rRNA gene, a phylogenetic marker for prokaryotes, prediction of the composition of the entire bacterial community is made possible. © 2017 by John Wiley & Sons, Inc., (Copyright © 2017 John Wiley & Sons, Inc.)
- Published
- 2017
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.